Home > Analytics > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 507789     NSE : JAGSNPHARM    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Aug 12,2022
Price(EOD): ₹ 381.00
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 998.22 Cr
Value of ₹ 1 Lac invested in JAGSONPAL PHARMACEUTICALS
on Aug 14,2017 (price: ₹ 32.25)

₹ 1 L

₹ 11.81 L

1W : 10.3% 1M : 5.9% 1Y : 112.4%
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
JAGSONPAL PHARMACEUTICALS 10.3% 5.9% 112.4%
SUN PHARMACEUTICAL INDUSTRIES -0.2% 6.2% 16%
DIVIS LABORATORIES -4.7% -1.3% -19.7%
DR REDDYS LABORATORIES 2.6% -5.4% -11%
CIPLA -0.7% 7.8% 13.8%
GLAND PHARMA 4.5% -3.4% -44.2%
PIRAMAL ENTERPRISES 11.2% 13.1% -31.4%
CADILA HEALTHCARE 8.3% 5.1% -33.9%
TORRENT PHARMACEUTICALS -1.1% 3.5% 1.4%

FUNDAMENTAL ANALYSIS OF JAGSONPAL PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF JAGSONPAL PHARMACEUTICALS

 
Valuation Score
[As on : Aug 12,2022 ]

Ratio Standalone
P/E
P/B
P/S
58.53
P/E Calculated based on EPS of 6.51
[ Mar2021 - Standalone Results ]

8.75
P/B Calculated based on Book Value of 43.55
[ Mar2021 - Standalone Results ]

4.4
P/S Calculated based on Revenues of 226.696 Cr
[ TTM - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 18% undervalued companies ! Discover More →

FAIR VALUE OF JAGSONPAL PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
1122%
561%
1106%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF JAGSONPAL PHARMACEUTICALS



JAGSONPAL PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF JAGSONPAL PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.06
0.06
0.04
0.05
-
-
-
-
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF JAGSONPAL PHARMACEUTICALS

Pledged Promoter Shares
0 %
As on : Jun2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF JAGSONPAL PHARMACEUTICALS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
16.23%
923.6%
261.81%
1437.5%
12.1%
-30.8%
-92.58%
-94.61%
QtrlyTrend
2
Latest Qtr: Jun2022
Quarterly Result Analysis →


JAGSONPAL PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about JAGSONPAL PHARMACEUTICALS


Is JAGSONPAL PHARMACEUTICALS good for long term investment?

As on Aug 12,2022, the Fundamentals of JAGSONPAL PHARMACEUTICALS look Poor and hence it may not be good for long term investment ! See Financial Performance of JAGSONPAL PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is JAGSONPAL PHARMACEUTICALS UnderValued or OverValued?

As on Aug 12,2022, JAGSONPAL PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of JAGSONPAL PHARMACEUTICALS ?

As on Aug 12,2022, the Intrinsic Value of JAGSONPAL PHARMACEUTICALS is Rs. 31.58 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 31.19
Fair Value [Median EV / Sales Model] : Rs. 57.61
Fair Value [Median Price / Sales Model] : Rs. 31.58
Median Fair Value of JAGSONPAL PHARMACEUTICALS : Rs. 31.58

Is JAGSONPAL PHARMACEUTICALS trading at a Premium or Discount?

As on Aug 12,2022, JAGSONPAL PHARMACEUTICALS is trading at a Premium of 1106% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].